These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 23264591)
1. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Schaer DJ; Buehler PW; Alayash AI; Belcher JD; Vercellotti GM Blood; 2013 Feb; 121(8):1276-84. PubMed ID: 23264591 [TBL] [Abstract][Full Text] [Related]
2. Modular Platform for the Development of Recombinant Hemoglobin Scavenger Biotherapeutics. Buzzi RM; Owczarek CM; Akeret K; Tester A; Pereira N; Butcher R; Brügger-Verdon V; Hardy MP; Illi M; Wassmer A; Vallelian F; Humar R; Hugelshofer M; Buehler PW; Gentinetta T; Schaer DJ Mol Pharm; 2021 Aug; 18(8):3158-3170. PubMed ID: 34292741 [TBL] [Abstract][Full Text] [Related]
3. When might transferrin, hemopexin or haptoglobin administration be of benefit following the transfusion of red blood cells? Buehler PW; Karnaukhova E Curr Opin Hematol; 2018 Nov; 25(6):452-458. PubMed ID: 30281034 [TBL] [Abstract][Full Text] [Related]
4. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease. Quimby KR; Hambleton IR; Landis RC Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635 [TBL] [Abstract][Full Text] [Related]
5. The Mechanism of Proinflammatory HDL Generation in Sickle Cell Disease Is Linked to Cell-Free Hemoglobin via Haptoglobin. Ji X; Feng Y; Tian H; Meng W; Wang W; Liu N; Zhang J; Wang L; Wang J; Gao H PLoS One; 2016; 11(10):e0164264. PubMed ID: 27716784 [TBL] [Abstract][Full Text] [Related]
6. Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron. Pires IS; Berthiaume F; Palmer AF Annu Rev Biomed Eng; 2023 Jun; 25():1-21. PubMed ID: 37289555 [TBL] [Abstract][Full Text] [Related]
7. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity. Deuel JW; Vallelian F; Schaer CA; Puglia M; Buehler PW; Schaer DJ Free Radic Biol Med; 2015 Dec; 89():931-43. PubMed ID: 26475040 [TBL] [Abstract][Full Text] [Related]
8. Haptoglobin Therapeutics and Compartmentalization of Cell-Free Hemoglobin Toxicity. Buehler PW; Humar R; Schaer DJ Trends Mol Med; 2020 Jul; 26(7):683-697. PubMed ID: 32589936 [TBL] [Abstract][Full Text] [Related]
9. Hemolysis, free hemoglobin toxicity, and scavenger protein therapeutics. Vallelian F; Buehler PW; Schaer DJ Blood; 2022 Oct; 140(17):1837-1844. PubMed ID: 35660854 [TBL] [Abstract][Full Text] [Related]
10. Coadministration of PEGylated apohemoglobin and haptoglobin can limit vascular dysfunction in the microcirculation and prevent acute inflammation. Munoz CJ; Lucas D; Muller CR; Martinez J; O'Boyle Q; Pires IS; Palmer AF; Cabrales P J Appl Physiol (1985); 2024 Oct; 137(4):934-944. PubMed ID: 39143905 [TBL] [Abstract][Full Text] [Related]
11. New Insights into Hemopexin-Binding to Hemin and Hemoglobin. Lechuga GC; Napoleão-Pêgo P; Morel CM; Provance DW; De-Simone SG Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409149 [TBL] [Abstract][Full Text] [Related]
12. The Role of Circulating Cell-Free Hemoglobin in Sepsis-Associated Acute Kidney Injury. Kerchberger VE; Ware LB Semin Nephrol; 2020 Mar; 40(2):148-159. PubMed ID: 32303278 [TBL] [Abstract][Full Text] [Related]
14. Corynebacterium diphtheriae Iron-Regulated Surface Protein HbpA Is Involved in the Utilization of the Hemoglobin-Haptoglobin Complex as an Iron Source. Lyman LR; Peng ED; Schmitt MP J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29311283 [No Abstract] [Full Text] [Related]
15. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. Baek JH; D'Agnillo F; Vallelian F; Pereira CP; Williams MC; Jia Y; Schaer DJ; Buehler PW J Clin Invest; 2012 Apr; 122(4):1444-58. PubMed ID: 22446185 [TBL] [Abstract][Full Text] [Related]
16. The role of RBC destruction in vascular regions with high turbulence on atherosclerosis. Olgun A; Akman S; Erbil MK Med Hypotheses; 2004; 63(2):283-4. PubMed ID: 15236792 [TBL] [Abstract][Full Text] [Related]
18. Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Schaer DJ; Vinchi F; Ingoglia G; Tolosano E; Buehler PW Front Physiol; 2014; 5():415. PubMed ID: 25389409 [TBL] [Abstract][Full Text] [Related]
19. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease. Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786 [TBL] [Abstract][Full Text] [Related]
20. Hemopexin increases the neurotoxicity of hemoglobin when haptoglobin is absent. Chen-Roetling J; Ma SK; Cao Y; Shah A; Regan RF J Neurochem; 2018 Jun; 145(6):464-473. PubMed ID: 29500821 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]